Navigation Links
Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress 'A Design for a Bundled End Stage Renal Disease Prospective Payment System'
Date:2/21/2008

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- The following is a statement by Robert D. Foreman, President of The Kidney Care Council:

"The Kidney Care Council (KCC) supports the findings of the Centers for Medicare & Medicaid Services (CMS) which in a long awaited report yesterday made clear that the time for a modernized and fully bundled case-mix adjusted prospective payment system for dialysis services is upon us. We could not agree more.

"For too long, the dialysis payment system has languished far behind other prospective payment systems in Medicare and has suffered from a lack of an annual updating mechanism. We are pleased to see the report recognizes the under-funding of the composite payment rate which cites the average cost of a treatment was $162.00 versus a reimbursement of $143.20.

"The report leaves open some details about the bundle's basic design features that need to be resolved for a new payment system to be fully successful. Specifically, the success of the revised payment mechanism will depend largely on the establishment of an appropriate rate at the outset as well as the design of an annual update mechanism. However, we are pleased by the progress and insights in the report and are eager to work collaboratively with CMS and with Congress this year.

"The KCC also applauds the work of those in the Government Accountability Office, the Medicare Payment Advisory Commission, and in Congress in advancing the payment modernization cause. The CMS report is a fitting culmination to more than a decade of thoughtful work by CMS and leading researchers on how best to reimburse care for Medicare's most vulnerable beneficiaries. Congress now has before it a concrete and detailed proposal. Now, let the hard work of making it happen begin.

"The KCC has endorsed payment reform and has taken a collaborative approach to positive change for the dialysis payment system, working closely with Congress, CMS, and pa
'/>"/>

SOURCE Kidney Care Council (KCC)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
2. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
3. AHIP Statement on New York Attorney Generals Announcement
4. NCPA Statement on Economic Stimulus Package
5. Blue Cross of California Statement
6. Statement by James P. Firman, Chair Leadership Council of Aging Organizations (LCAO) on the Presidents FY2009 Budget Proposal
7. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
8. NCPA Statement in Response to President Bushs FY 2009 Budget Proposal
9. NCPA Statement on White House Campaign to End Teenage Prescription Drug Abuse
10. Statement of the American Diabetes Association on the Administrations Proposal to Undermine Funds for Research, Prevention and Treatment in FY09
11. NutraCea Files Universal Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:eDiets.com(R) Announces Q3 2008 Results 2Health News:eDiets.com(R) Announces Q3 2008 Results 3Health News:eDiets.com(R) Announces Q3 2008 Results 4Health News:eDiets.com(R) Announces Q3 2008 Results 5Health News:eDiets.com(R) Announces Q3 2008 Results 6Health News:eDiets.com(R) Announces Q3 2008 Results 7Health News:Pelvic Inflammation Puts Girls at Risk for Repeat STIs 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 2Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 3Health News:Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 2Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 3Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 4Health News:Top NY Court Blinks in 'First Department' WPP Discrimination Power Play 5Health News:Leading Scientists From Around the World Headed to Kansas for Symposium on Combating Deadly Infectious Diseases 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 2Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 3Health News: FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause 4
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Abbott Declares 343rd Consecutive Quarterly Dividend 14129 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 1Medical Device Manufacturer MRPC Awarded ISO 13485 Certification 57543 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 1Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 2Global Med Technologies Inc s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wedn 57541 3